BioSpace News Archive

Diabetes is a major healthcare challenge across the world as its incidence grows considerably over the world owing to poor lifestyle choices such as sedentary living, poor and unbalanced diets and excessive stress.

Nitrile, or acrylonitrile-butadiene rubber, is a material made of organic chemicals. Nitrile gloves do not contain latex proteins and have a minimal content of vulcanisation accelerators.

In the domain of patient’s health management, medical nutrition is a focused component. It makes an assessment of the nutrition status of the patients and assists in improving the immune system of the patient.

Telemedicine is the use of telecommunications and information technologies to share information and provide clinical care, education, public health, and administrative services

JUD care, a leading high-tech enterprise in the field of smart medical and healthcare solutions, has kicked off its international partner program for its newly-launched portable ward sRoom, a revolutionary solution for patient isolation that enables medical staff to quickly set up emergency isolation rooms in different locations.

First therapy recommended for full marketing authorization in the EU for eligible patients with confirmed diagnosis of late infantile or early juvenile MLD variants

First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients suffering from spasticity.

Alnylam Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of lumasiran, an investigational RNAi therapeutic targeting the hydroxyacid oxidase 1 mRNA – encoding glycolate oxidase – in development for the treatment of primary hyperoxaluria type 1.

Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it will report its audited financial results for the full year ended June 30, 2020 on Tuesday, October 27 2020.

Longer-Term Data from the Registration-Enabling Phase 1/2 Trial for Leukocyte Adhesion Deficiency-I Demonstrate Safety and Efficacy of RP-L201